| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, Department of Medicine, Northwestern University Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611
We cultured primary human mammary epithelial cells from five reduction mammoplasties and five breast carcinomas and attempted to improve culture conditions and define cell populations grown. Normal cells cultured on Matrigel basement membrane-like substance formed multicellular three-dimensional structures reminiscent of tissue ducts and alveoli, while malignant cells remained as single cells crawing through Matrigel much as malignant cells separate and invade basement membrane in vivo. This re-creation of normal and malignant breast cell morphology may facilitate studies of breast cancer cell biology and determination of malignant cell authenticity in culture. Growth of cells in a reduced oxygen concentration of 12% improved cell proliferation over room air (21%); however, cells could not proliferate in a completely physiological oxygen concentration of 6%, perhaps because of the medium used. We developed an improved medium for malignant cell growth, which lengthened their life span in culture, and a completely defined medium which supported cell proliferation for six passages. Methods to determine the epithelial nature of mammary epithelial cells are illustrated and discussed. The authenticity of malignant cells in culture was suggested by their proliferation without certain growth factors required for normal cell growth or with transforming growth factor-ß, which arrests normal cell proliferation, and by their contact independence.
1 This study was supported in part by the Lester Wood Foundation.
2 To whom requests for reprints should be addressed, at Northwestern University Medical School, 303 East Chicago Avenue, Olson Pavilion, Room 8524, Chicago, IL 60611.
Received 10/16/92. Accepted 3/23/93.
This article has been cited by other articles:
![]() |
F. Docquier, D. Farrar, V. D'Arcy, I. Chernukhin, A. F. Robinson, D. Loukinov, S. Vatolin, S. Pack, A. Mackay, R. A. Harris, et al. Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis Cancer Res., June 15, 2005; 65(12): 5112 - 5122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kominsky, M. Vali, D. Korz, T. G. Gabig, S. A. Weitzman, P. Argani, and S. Sukumar Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4 Am. J. Pathol., May 1, 2004; 164(5): 1627 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Douglas, Y. Akiyama, H. Carraway, S. A. Belinsky, M. Esteller, E. Gabrielson, S. Weitzman, T. Williams, J. G. Herman, and S. B. Baylin Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2{alpha} Expression during Progression of Breast Cancer Cancer Res., March 1, 2004; 64(5): 1611 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Evron, C. B. Umbricht, D. Korz, V. Raman, D. M. Loeb, B. Niranjan, L. Buluwela, S. A. Weitzman, J. Marks, and S. Sukumar Loss of Cyclin D2 Expression in the Majority of Breast Cancers Is Associated with Promoter Hypermethylation Cancer Res., March 1, 2001; 61(6): 2782 - 2787. [Abstract] [Full Text] |
||||
![]() |
D. M. Loeb, E. Evron, C. B. Patel, P. M. Sharma, B. Niranjan, L. Buluwela, S. A. Weitzman, D. Korz, and S. Sukumar Wilms' Tumor Suppressor Gene (WT1) Is Expressed in Primary Breast Tumors Despite Tumor-specific Promoter Methylation Cancer Res., February 1, 2001; 61(3): 921 - 925. [Abstract] [Full Text] |
||||
![]() |
J Huang, J. Hardy, Y Sun, and J. Shively Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F J. Cell Sci., January 12, 1999; 112(23): 4193 - 4205. [Abstract] [PDF] |
||||
![]() |
S Stahl, S Weitzman, and J. Jones The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis J. Cell Sci., January 1, 1997; 110(1): 55 - 63. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |